ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

ECOG, ACRIN Form Single Cooperative Group

May 18, 2012

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994